Reed GW, Rossi JE, Cannon CP (2017) Acute myocardial infarction. Lancet 389:197–210
Anderson JL, Morrow DA (2017) Acute myocardial infarction. N Engl J Med 376:2053–2064
Chow SL, Maisel AS, Anand I et al (2017) Role of biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the american heart association. Circulation 135:e1054–e1091
Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22:50–60
Jozefczuk E, Guzik TJ, Siedlinski M (2020) Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology. Pharmacol Res 156:104793
Means CK, Brown JH (2009) Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res 82:193–200
CAS PubMed PubMed Central Google Scholar
Hofmann U, Burkard N, Vogt C et al (2009) Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. Cardiovasc Res 83:285–293
Cannavo A, Rengo G, Liccardo D et al (2013) β1-Adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: Protective role of S1PR1 cardiac gene therapy. Circulation 128:1612–1622
CAS PubMed PubMed Central Google Scholar
Cannavo A, Liccardo D, Komici K et al (2017) Sphingosine kinases and sphingosine 1-phosphate receptors: signaling and actions in the cardiovascular system. Front Pharmacol 8:556
PubMed PubMed Central Google Scholar
Kuang Y, Li X, Liu X et al (2021) Vascular endothelial S1PR1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction. Cardiovasc Res 117:585–599
Bg S, Gowda D, Kain V et al (2021) Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts. Am J Physiol Heart Circ Physiol 321:H599-h611
Polzin A, Dannenberg L, Benkhoff M et al (2023) Sphingosine-1-phosphate improves outcome of no-reflow acute myocardial infarction via sphingosine-1-phosphate receptor 1. ESC Heart Fail 10:334–341
Klyachkin YM, Nagareddy PR, Ye S et al (2015) Pharmacological elevation of circulating bioactive phosphosphingolipids enhances myocardial recovery after acute infarction. Stem Cells Transl Med 4:1333–1343
CAS PubMed PubMed Central Google Scholar
Bandhuvula P, Honbo N, Wang GY et al (2011) S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. Am J Physiol Heart Circ Physiol 300:H1753-1761
CAS PubMed PubMed Central Google Scholar
Kuai F, Wang L, Su J, Wang Y, Han Y, Zhou S (2019) Exploring the protective role and the mechanism of sphingosine 1 phosphate in endotoxic cardiomyocytes. Shock 52:468–476
CAS PubMed PubMed Central Google Scholar
Varasteh Z, Mohanta S, Robu S et al (2019) Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J Nucl Med 60:1743–1749
CAS PubMed PubMed Central Google Scholar
Heo GS, Kopecky B, Sultan D et al (2019) Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart. Circ Res 124:881–890
CAS PubMed PubMed Central Google Scholar
Jiang H, Joshi S, Liu H et al (2021) In vitro and in vivo investigation of s1pr1 expression in the central nervous system using [(3)H]CS1P1 and [(11)C]CS1P1. ACS Chem Neurosci 12:3733–3744
Qiu L, Jiang H, Yu Y et al (2022) Radiosynthesis and evaluation of a fluorine-18 radiotracer [18F]FS1P1 for imaging sphingosine-1-phosphate receptor 1. Org Biomol Chem 20:1041–1052
CAS PubMed PubMed Central Google Scholar
Qiu L, Jiang H, Zhou C et al (2023) Discovery of a promising fluorine-18 positron emission tomography radiotracer for imaging sphingosine-1-phosphate receptor 1 in the brain. J Med Chem 66:4671–4688
CAS PubMed PubMed Central Google Scholar
Liu H, Laforest R, Gu J et al (2020) Acute rodent tolerability, toxicity, and radiation dosimetry estimates of the S1P1-specific radioligand [11C]CS1P1. Mol Imaging Biol 22:285–292
CAS PubMed PubMed Central Google Scholar
Brier MR, Hamdi M, Rajamanikam J et al (2022) Phase 1 evaluation of 11C-CS1P1 to assess safety and dosimetry in human participants. J Nucl Med 63:1775–1782
CAS PubMed PubMed Central Google Scholar
Liu H, Jin H, Yue X et al (2016) PET Imaging study of S1PR1 expression in a rat model of multiple sclerosis. Mol Imaging Biol 18:724–732
CAS PubMed PubMed Central Google Scholar
Nossuli TO, Lakshminarayanan V, Baumgarten G et al (2000) A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol 278:H1049-1055
Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J (2022) Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 43:2549–2561
CAS PubMed PubMed Central Google Scholar
Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF (1999) Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 41:586–593
Kunkel GT, Maceyka M, Milstien S, Spiegel S (2013) Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov 12:688–702
CAS PubMed PubMed Central Google Scholar
Brinkmann V, Billich A, Baumruker T et al (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9:883–897
Mann DL (2012) Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers. Circulation 125:2692–2694
PubMed PubMed Central Google Scholar
Keul P, van Borren MM, Ghanem A, Müller FU, Baartscheer A, Verkerk AO, Stümpel F, Schulte JS, Hamdani N, Linke WA, van Loenen P (2016) Sphingosine-1-phosphate receptor 1 regulates cardiac function by modulating Ca2+ sensitivity and Na+/H+ exchange and mediates protection by ischemic preconditioning. J Am Heart Assoc 5(5):e003393
PubMed PubMed Central Google Scholar
Clay H, Wilsbacher LD, Wilson SJ et al (2016) Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development. Dev Biol 418:157–165
CAS PubMed PubMed Central Google Scholar
Allende ML, Yamashita T, Proia RL (2003) G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102:3665–3667
Li Q, Zhou C, Zhao K et al (2022) Lymphatic endothelial sphingosine 1-phosphate receptor 1 enhances macrophage clearance via lymphatic system following myocardial infarction. Front Cardiovasc Med 9:872102
Comments (0)